JP Patent

JP4501076B2 — 携帯無線通信端末

Assigned to Sony Corp · Expires 2010-07-14 · 16y expired

What this patent protects

Patent listed against Bupivacaine Hydrochloride And Epinephrine.

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: JP4501076B2
Jurisdiction: JP
Classification: —
Expires: 2010-07-14
Drug substance claim: No
Drug product claim: No
Assignee: Sony Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.